相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses
Eloi R. Verrier et al.
HEPATOLOGY (2016)
Identification of FDA-approved drugs that target hepatitis B virus transcription
M. A. A. van de Klundert et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators
Dawei Cai et al.
ANTIVIRAL RESEARCH (2016)
Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation
Li Yang et al.
ANTIVIRAL RESEARCH (2016)
Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
Andrew Vaillant
ANTIVIRAL RESEARCH (2016)
Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors
Pinghu Zhang et al.
ANTIVIRAL RESEARCH (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank et al.
JOURNAL OF HEPATOLOGY (2016)
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Pavel Bogomolov et al.
JOURNAL OF HEPATOLOGY (2016)
Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination
Danming Zhu et al.
JOURNAL OF IMMUNOLOGY (2016)
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors
Zongxing Qiu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx
Takahisa Kouwaki et al.
JOURNAL OF VIROLOGY (2016)
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
Christoph Seeger et al.
MOLECULAR THERAPY (2016)
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
Adrien Decorsiere et al.
NATURE (2016)
Re-Designed Recombinant Hepatitis B Virus Vectors Enable Efficient Delivery of Versatile Cargo Genes to Hepatocytes with Improved Safety
Weiya Bai et al.
VIRUSES-BASEL (2016)
The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state
Valentina Alarcon et al.
SCIENTIFIC REPORTS (2016)
A Novel Pyridazinone Derivative Inhibits Hepatitis B Virus Replication by Inducing Genome-Free Capsid Formation
Ya-Juan Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the magic bullet to kill cccDNA
Ejuan Zhang et al.
ANTIVIRAL RESEARCH (2015)
Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development
Daniel N. Clark et al.
ANTIVIRAL RESEARCH (2015)
NTCP opens the door for hepatitis B virus infection
Huan Yan et al.
ANTIVIRAL RESEARCH (2015)
The hepatitis B virus ribonuclease H as a drug target
John E. Tavis et al.
ANTIVIRAL RESEARCH (2015)
Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics
Ju-Tao Guo et al.
ANTIVIRAL RESEARCH (2015)
Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2015)
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
Chunsheng Dong et al.
ANTIVIRAL RESEARCH (2015)
Present and Future Therapies of Hepatitis B: From Discovery to Cure
T. Jake Liang et al.
HEPATOLOGY (2015)
Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
Xing Liu et al.
JOURNAL OF GENERAL VIROLOGY (2015)
HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase
Lise Riviere et al.
JOURNAL OF HEPATOLOGY (2015)
The Interface between Hepatitis B Virus Capsid Proteins Affects Self-Assembly, Pregenomic RNA Packaging, and Reverse Transcription
Zhenning Tan et al.
JOURNAL OF VIROLOGY (2015)
Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
Faseeha Noordeen et al.
PLOS ONE (2015)
High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein
Klaus Klumpp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation
Philipp Tropberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Molecular biology of hepatitis B virus infection
Christoph Seeger et al.
VIROLOGY (2015)
Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
Jie Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
Vyas Ramanan et al.
SCIENTIFIC REPORTS (2015)
A Dual-Reporter System for Real-Time Monitoring and High-throughput CRISPR/Cas9 Library Screening of the Hepatitis C Virus
Qingpeng Ren et al.
SCIENTIFIC REPORTS (2015)
Hydroxylated Tropolones Inhibit Hepatitis B Virus Replication by Blocking Viral Ribonuclease H Activity
Gaofeng Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The Hepatitis B Virus (HBV) HBx Protein Activates AKT To Simultaneously Regulate HBV Replication and Hepatocyte Survival
Siddhartha Rawat et al.
JOURNAL OF VIROLOGY (2015)
Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion
Yi-Bin Xu et al.
ANTIVIRAL RESEARCH (2014)
Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity
Catherine W. Cai et al.
ANTIVIRAL RESEARCH (2014)
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Stephan Urban et al.
GASTROENTEROLOGY (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)
Koichi Watashi et al.
HEPATOLOGY (2014)
Immune Responses to HCV and Other Hepatitis Viruses
Su-Hyung Park et al.
IMMUNITY (2014)
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
Shirin Nkongolo et al.
JOURNAL OF HEPATOLOGY (2014)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
The Tudor Domain Protein Spindlin1 Is Involved in Intrinsic Antiviral Defense against Incoming Hepatitis B Virus and Herpes Simplex Virus Type 1
Aurelie Ducroux et al.
PLOS PATHOGENS (2014)
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
Su-Ru Lin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Targeting Hepatitis B Virus With CRISPR/Cas9
Christoph Seeger et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
Jinhong Chang et al.
ACTA PHARMACEUTICA SINICA B (2014)
Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly
Guoyi Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Chronic hepatitis B: What should be the goal for new therapies?
Timothy M. Block et al.
ANTIVIRAL RESEARCH (2013)
β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity
Yuan Hu et al.
ANTIVIRAL RESEARCH (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?
Robert Thimme et al.
JOURNAL OF HEPATOLOGY (2013)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz et al.
JOURNAL OF HEPATOLOGY (2013)
Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids
Matthew R. Campagna et al.
JOURNAL OF VIROLOGY (2013)
Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
Christine I. Wooddell et al.
MOLECULAR THERAPY (2013)
Assembly-Directed Antivirals Differentially Bind Quasiequivalent Pockets to Modify Hepatitis B Virus Capsid Tertiary and Quaternary Structure
Sarah P. Katen et al.
STRUCTURE (2013)
Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes
Fei Liu et al.
PLOS PATHOGENS (2013)
The Hepatitis B Virus Ribonuclease H Is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes
John E. Tavis et al.
PLOS PATHOGENS (2013)
Hepatitis B Virus X Protein Stimulates Gene Expression Selectively From Extrachromosomal DNA Templates
Pieter C. van Breugel et al.
HEPATOLOGY (2012)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A CC-SAM, for Coiled Coil-Sterile α Motif, Domain Targets the Scaffold KSR-1 to Specific Sites in the Plasma Membrane
Dorothy Koveal et al.
SCIENCE SIGNALING (2012)
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
J. J. Ott et al.
VACCINE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state
Yan-Hai Guo et al.
EPIGENETICS (2011)
Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection
Julie Lucifora et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis B surface antigen seroclearance during chronic HBV infection
Chia-Ming Chu et al.
ANTIVIRAL THERAPY (2010)
HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice
Masataka Tsuge et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Hepatitis B Virus Requires Intact Caveolin-1 Function for Productive Infection in HepaRG Cells
Alina Macovei et al.
JOURNAL OF VIROLOGY (2010)
Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus
Chunxiao Xu et al.
JOURNAL OF VIROLOGY (2010)
Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes
Tricia L. Gearhart et al.
VIROLOGY (2010)
Benefits and Risks of Nucleoside Analog Therapy for Hepatitis B
Jules L. Dienstag
HEPATOLOGY (2009)
Benefits and Risks of Interferon Therapy for Hepatitis B
Robert Perrillo
HEPATOLOGY (2009)
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
Laura Belloni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
Joerg Petersen et al.
NATURE BIOTECHNOLOGY (2008)
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans
Andreas Schulze et al.
HEPATOLOGY (2007)
A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion
Anne Marie Dougherty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up
Chia-Ming Chu et al.
HEPATOLOGY (2007)
Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1
Christina R. Bourne et al.
JOURNAL OF VIROLOGY (2006)
BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly
Stephen J. Stray et al.
JOURNAL OF MOLECULAR RECOGNITION (2006)
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
Karsten Wursthorn et al.
HEPATOLOGY (2006)
Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones
T Pollicino et al.
GASTROENTEROLOGY (2006)
Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression
M Melegari et al.
JOURNAL OF VIROLOGY (2005)
A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly
SJ Stray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy
JJY Sung et al.
GASTROENTEROLOGY (2005)
Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function
JM Hu et al.
JOURNAL OF VIROLOGY (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Calcium signaling by HBx protein in hepatitis B virus DNA replication
MJ Bouchard et al.
SCIENCE (2001)
Structural organization of the hepatitis B virus minichromosome
CT Bock et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis
Y Zhu et al.
JOURNAL OF VIROLOGY (2001)
分享论文
